Anti-inflammatory Effects of Colchicine in PCI

PHASE4CompletedINTERVENTIONAL
Enrollment

280

Participants

Timeline

Start Date

May 30, 2013

Primary Completion Date

August 30, 2019

Study Completion Date

December 13, 2021

Conditions
Coronary Artery Disease
Interventions
DRUG

Colchicine

Colchicine 1.2mg 1 to 2 hours prior PCI, followed by 0.6mg 1 hour later

DRUG

Placebo

Placebo 1 to 2 hours prior PCI, followed by Placebo 1 hour later

Trial Locations (3)

10010

Manhattan VA Hospital, New York

10016

Bellevue Hospital Center, New York

New York Langone Medical Center, New York

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Takeda

INDUSTRY

lead

NYU Langone Health

OTHER